Kevin E. Weddington

Array ( [id] => 6433598 [patent_doc_number] => 20100278804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders' [patent_app_type] => utility [patent_app_number] => 12/837067 [patent_app_country] => US [patent_app_date] => 2010-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13311 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278804.pdf [firstpage_image] =>[orig_patent_app_number] => 12837067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9299852 [patent_doc_number] => 08648080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-11 [patent_title] => 'Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility' [patent_app_type] => utility [patent_app_number] => 13/383056 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 10836 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097715 [patent_doc_number] => 20110003803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/829973 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5125 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003803.pdf [firstpage_image] =>[orig_patent_app_number] => 12829973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313657 [patent_doc_number] => 20120190690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'ELTOPRAZINE FOR THE TREATMENT OF WEIGHT DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/381203 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6895 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13381203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10876322 [patent_doc_number] => 08901109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-02 [patent_title] => 'Quercetin-containing compositions' [patent_app_type] => utility [patent_app_number] => 12/821287 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2701 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12821287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574858 [patent_doc_number] => 20100273703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Co-Therapy For Diabetic Conditions' [patent_app_type] => utility [patent_app_number] => 12/816653 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6499 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273703.pdf [firstpage_image] =>[orig_patent_app_number] => 12816653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538338 [patent_doc_number] => 08314059 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Diabetic nephropathy therapies' [patent_app_type] => utility [patent_app_number] => 12/802373 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14992 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12802373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817397 [patent_doc_number] => 20120064017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'BORINIC COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/319802 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11178 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064017.pdf [firstpage_image] =>[orig_patent_app_number] => 13319802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212411 [patent_doc_number] => 20110135711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Methods and Compositions for Delivery of Catecholic Butanes for Treatment of Tumors' [patent_app_type] => utility [patent_app_number] => 12/790894 [patent_app_country] => US [patent_app_date] => 2010-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26018 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135711.pdf [firstpage_image] =>[orig_patent_app_number] => 12790894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6613404 [patent_doc_number] => 20100310460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'COMPOSITIONS AND METHODS FOR CHELATION THERAPY' [patent_app_type] => utility [patent_app_number] => 12/790132 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24358 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310460.pdf [firstpage_image] =>[orig_patent_app_number] => 12790132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9389336 [patent_doc_number] => 08685934 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'Methods for treating extreme insulin resistance in patients resistant to previous treatment with other anti-diabetic drugs employing an SGLT2 inhibitor and compositions thereof' [patent_app_type] => utility [patent_app_number] => 13/321103 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20123 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211633 [patent_doc_number] => 20120129938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Anti-oomycetes' [patent_app_type] => utility [patent_app_number] => 13/321997 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5500 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129938.pdf [firstpage_image] =>[orig_patent_app_number] => 13321997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6265359 [patent_doc_number] => 20100297761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Novel Use of Liver X Receptor Agonists' [patent_app_type] => utility [patent_app_number] => 12/787881 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13137 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297761.pdf [firstpage_image] =>[orig_patent_app_number] => 12787881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251984 [patent_doc_number] => 20120156310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'METHOD FOR PREDICTION OF THERAPEUTIC EFFECT OF CHEMOTHERAPY EMPLOYING EXPRESSION LEVEL OF DIHYDROPYRIMIDINE DEHYDROGENASE GENE AS MEASURE' [patent_app_type] => utility [patent_app_number] => 13/321202 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6926 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156310.pdf [firstpage_image] =>[orig_patent_app_number] => 13321202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662411 [patent_doc_number] => 08809386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Use of dynamin ring stabilizers' [patent_app_type] => utility [patent_app_number] => 13/321415 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 15671 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282513 [patent_doc_number] => 08216614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis' [patent_app_type] => utility [patent_app_number] => 12/784305 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5827 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12784305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221797 [patent_doc_number] => 20120136004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'NEW COMBINATION THERAPY IN TREATMENT OF CANCER AND FIBROTIC DISEASES' [patent_app_type] => utility [patent_app_number] => 13/318395 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6414 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199418 [patent_doc_number] => 20120122870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'Treatment Of Ischemia-Reperfusion Injury' [patent_app_type] => utility [patent_app_number] => 13/319392 [patent_app_country] => US [patent_app_date] => 2010-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22108 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122870.pdf [firstpage_image] =>[orig_patent_app_number] => 13319392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6507388 [patent_doc_number] => 20100210583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'NOVEL ANTIFOLATE COMBINATION THERAPIES' [patent_app_type] => utility [patent_app_number] => 12/768920 [patent_app_country] => US [patent_app_date] => 2010-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5549 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210583.pdf [firstpage_image] =>[orig_patent_app_number] => 12768920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221854 [patent_doc_number] => 20120136061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'LYCOPENE AND RESVERATROL COMPOSITIONS FOR NK CELL ACTIVATION RESULTING IN ANTI-NEOPLASTIC EFFECT' [patent_app_type] => utility [patent_app_number] => 13/320480 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4861 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320480 [rel_patent_id] =>[rel_patent_doc_number] =>)